Call us today: +1 (304) 470-2225
English
You can use WPML or Polylang and their language switchers in this area.
0 $0.00

Cart

No products in the cart.

View Cart Checkout

Menu

Mellalta Providing Essential Solutions for Successful Business

Our goal is to help the Pharma & Biotech Companies to increase their impact and make their decisions easier & more effective.

Get in touch

Your Questions, Our Expert Answers

View Services

The Mellalta Meets Services

Bringing the best support to your team!

Bespoke Tumour & Rare Disease Decks

Bespoke Decks in Oncology, Rare Disease, Neurology & others

Learn More
Mellalta Meets Report Store

Disease Report Store

Disease Report Store provides latest reports, strategies and Key Leader opinions in this market

Learn More
Win MM Consulting Services

Market Research Consulting

Flex your market research muscles with us!

Learn More
MM Competitive Intelligence

Competitive Intelligence

Let MM help you uncover hidden opportunities and competitive advantages.

Learn More

The Mellalta Meets Report Store

One stop disease reports store for all your business needs.

HER2-Low Gastric / Gastroesophageal Junction (GEJ) Adenocarcinoma | Primary Research (KOL’s Insight) | Market Intelligence | Epidemiology & Market Forecast-2034

HER2-Low Gastric / Gastroesophageal Junction (GEJ) Adenocarcinoma | Primary Research (KOL’s Insight) | Market Intelligence | Epidemiology & Market Forecast-2034

 $6,989.00 – $20,967.00 Select options

Head and neck squamous cell carcinoma (LA-HNSCC and Metastatic HNSCC)–Tumour Deck

 $11,800.00 – $20,000.00 Select options
Mellalta Meets HER2-Low Metastatic Breast Cancer (mBC)–Tumour Deck

HER2-Low Metastatic Breast Cancer –Tumour Deck

 $11,800.00 – $20,000.00 Select options
Mellalta Meets- HER2-Low Breast Cancer (BC)– Pipeline Analytics 2023

HER2-Low Breast Cancer– Pipeline Analytics 2023

 $2,500.00 – $7,500.00 Select options

Business Insights

Our latest business insights for your next investments!

Real-World KOL Perspectives Semaglutide & GLP-1 Agents in the Spotlight Mellalta Meets

Semaglutide: Real-World KOLs Opinions Seem Divided!

Read More
Mellalta Meets How Nanobiotix's Breakthrough NBTXR3 is Poised to Radically Transform the LA-HNSCC Landscape

How Nanobiotix’s Breakthrough NBTXR3 is Poised to Radically Transform the LA-HNSCC Landscape?

Read More
Mellalta Meets: Xevinapant Takes the Lead in LA-HNSCC

Xevinapant Takes the Lead: Merck’s Bold Market Strategies to Outshine Rivals in LA-HNSCC !

Read More
Obesity and NASH Lilly’s Retatrutide Mellalta Meets

What KOLs Revealed? Lilly’s Retatrutide as an Emerging Treatment Choice in NASH & Obesity

Read More

Careers

The Mellalta Meets Work Culture Difference

This is the opportunity to develop your ideas and thinking while having your efforts recognized from day one.

View Available Positions

Case Studies

Learn how we have helped businesses like yours!

artificial-intelligence-in-healthcare

Artificial Intelligence Diagnostic Tool–Due Diligence for Collaboration

Learn More
da-vinci_RAS

Robot-Assisted Surgical System–MedTech Market Intelligence

Learn More
Anti-Infective Market Entry

Anti-Infective–Market Access Strategies 

Learn More
Brand Protection

Hemophilia–Brand Protection & Competitive Intelligence

Learn More

Get in touch

Let’s keep the conversation going

Contact Us
Close Menu
 
Return to shop